Abstract:Background Colorectal cancer (CRC) remains a major cause of morbidity and mortality worldwide. Understanding the clinical and pathological characteristics of CRC patients is essential for improving diagnosis, treatment, and prognostication. S100 proteins play a crucial role in CRC by promoting tumor growth, metastasis, and inflammation through their involvement in various cellular processes such as proliferation, migration, and immune response modulation. Elevated levels of specific S100 proteins have been associated with poor prognosis and serve as potential biomarkers for early detection and therapeutic targets in CRC. This study aims to analyze the general and medical characteristics of CRC patients, with a particular focus on the expression patterns of S100A4 and S100A14 proteins and their correlation with tumor location and various clinical parameters. Methods This cross-sectional study included 98 CRC patients aged 21 to 92 years. Clinical data were collected from Vajeen Hospital (Duhok/ Iraq), including age, gender, and presenting symptoms. Pathological data such as tumor site, tumor size, tumor, node, and metastasis (TNM) stage, tumor grade angio-lymphatic invasion, perineural invasion, and metastasis were analyzed. The expression of S100A4 and S100A14 proteins was assessed using immunohistochemistry, and their correlation with clinico-pathological features and tumor location was evaluated using statistical analysis. Results The 98 patients with a mean age of 57.27 years. The majority were over 50 years old (68, 69.39%) with a nearly equal gender distribution. The most common symptom was bleeding per rectum (36, 36.74%). TNM staging revealed 25.51% (n=25) of patients at stage I, 32.65% (n=32) at stage II, 24.49% (n=24) at stage III, and 17.35% (n=17) at stage IV. Angio-lymphatic invasion was present in 65.31% (n=64) of patients, and lymph node invasion in 38.78% (n=38). All tumors were adenocarcinomas, with 82.65% (n=81) being intermediate grade. S100A4 expression was low in early-stage tumors but significantly higher in advanced stages (P < 0.0001). High S100A4 expression was associated with vascular invasion (P = 0.0006), perineural invasion (P = 0.0002), lymph node invasion (P < 0.0001), and metastasis (P = 0.0010). S100A14 expression was inversely correlated with disease severity. Low S100A14 expression was more common in advanced stages (P < 0.0001) and was associated with higher rates of vascular invasion (P = 0.0018), lymph node invasion (P < 0.0001), and metastasis (P = 0.0001). Conclusion This study highlights significant correlations between S100A4 and S100A14 expression with various clinico-pathological features in CRC patients. High S100A4 expression is linked with tumor aggressiveness, whereas low S100A14 expression is associated with advanced disease stages and increased metastasis. However, there is no observed correlation between the expression of these proteins and the tumor site.

S100A4 Over-Expression Underlies Lymph Node Metastasis and Poor Prognosis in Colorectal Cancer.

S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Expression Status of S100A14 and S100A4 Correlates with Metastatic Potential and Clinical Outcome in Colorectal Cancer after Surgery.

[Correlations of S100A4 Protein Expression to Invasion and Metastasis of Non-Small Cell Lung Cancer].

The Expression of S100A4 Protein in Tumor-stroma of Human Non-small Cell Lung Cancer and Its Clinical Significance

Expressions of S100A4 in lung cancer tissues and its clinical significance

In-depth analysis of lymph node metastasis-related sialylated protein profiling and their clinical and biological significance in colorectal cancer using mass spectrometry and multi-omics technologies

Overexpression of S100A2 Protein As a Prognostic Marker for Patients with Stage I Non Small Cell Lung Cancer

[Correlations of S100A4 and MMP9 Expressions to Infiltration, Metastasis and Prognosis of Non-Small Cell Lung Cancer].

High-Level Expression of S100a4 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Gastric Cancer

Correlation of S100A4 and S100A14 Expression With Clinico-Pathological Features and Tumor Location in Colorectal Cancer Patients

Overexpression of S100A4 is Closely Associated with the Progression and Prognosis of Gastric Cancer in Young Patients.

[Nuclear Expression of S100A4 is Associated with Lymph Node Metastasis in Gastric Carcinoma].

Overexpression of S100A4 protein may be associated with the development and progression of pancreatic cancer.

Modulated T-complex protein 1 ζ and peptidyl-prolyl cis-trans isomerase B are two novel indicators for evaluating lymph node metastasis in colorectal cancer: Evidence from proteomics and bioinformatics.

P2-025: the Correlation of the Differential Expression of S100A4 Gene (mts1) with the Differentiation and Metastasis of Lung Cancer

Restoration of S100A4 Expression Enhances Invasive and Metastatic Potentials of COLO16 Cutaneous Squamous Cancer Cells.

Downregulation of S100A4 Expression by RNA Interference Suppresses Cell Growth and Invasion in Human Colorectal Cancer Cells.

[Association Between Serum Levels of S100A8/S100A9 and Clinical Features of Colorectal Cancer Patients].

Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.